| Stage | CAT | % of rev | GENC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.7B | 100.00% | $34M | 100.00% | CAT ×611.80 |
| Gross profit | $7.3B | 35.54% | $9M | 27.91% | CAT +7.6pp |
| Operating income | $4.2B | 20.38% | $6M | 17.16% | CAT +3.2pp |
| Pre-tax income | $4.2B | 20.40% | $7M | 21.35% | GENC +1.0pp |
| Net income | $3.3B | 15.89% | $6M | 16.81% | GENC +0.9pp |
| Stage | CAT | GENC | Gap · A − B |
|---|---|---|---|
| Revenue | $20.7B100.00% | $34M100.00% | CAT ×611.80 |
| Gross profit | 35.54%$7.3B | 27.91%$9M | CAT +7.6pp |
| Operating income | 20.38%$4.2B | 17.16%$6M | CAT +3.2pp |
| Pre-tax income | 20.40%$4.2B | 21.35%$7M | GENC +1.0pp |
| Net income |
| 15.89%$3.3B |
| 16.81%$6M |
| GENC +0.9pp |
No shared counterparties.